Compugen Discloses Discovery Method for Drug Candidates That Interfere With Protein Conformations

Compugen Ltd. CGEN announced today the development of a method to identify novel therapeutic candidates to interfere with disease associated protein conformations and protein-protein interactions. This new in silico method relies on the prediction of hidden conformations of the proteins of interest, which is the subject of a scientific paper to be published in the journal Bioinformatics, and is now available online at this link.